CIK 0001862150 · <br>Emerging growth company
Cingulate Inc.
Sign in to watch- Ticker
- CING
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 863825535
- Phone
- (913) 942-2300
- Business address
- 1901 W. 47TH PLACE, KANSAS CITY, KS, 66205
- Former names
- Cingulate Inc.
Securities
- CING Common Stock Nasdaq
- CINGW Warrants Nasdaq
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2023-02-28 | Gilgallon Craig S. EVP and General Counsel | Grant or award · Stock Option (right to Buy) | +40,000 | 40,000 | ||
| 2023-02-28 | Callahan Jennifer L. Corporate Controller | Grant or award · Stock Option (right to Buy) | +20,000 | 20,000 | ||
| 2023-02-28 | Brams Matthew EVP and Chief Medical Officer | Grant or award · Stock Option (right to Buy) | +15,000 | 15,000 | ||
| 2022-12-30 | Silva Raul R. EVP and CSO | Grant or award · Stock Option (right to Buy) | +16,084 | 16,084 | ||
| 2022-12-16 | Schaffer Shane J. Chief Executive Officer | Purchase | +10,000 | $1.02 | $10K | 41,500 |
| 2022-12-16 | Schaffer Shane J. Chief Executive Officer | Purchase · Warrant to Purchase Common Stock | +200 | $0.26 | $52 | 70,738 |
| 2022-12-15 | Schaffer Shane J. Chief Executive Officer | Purchase · Warrant to Purchase Common Stock | +3,642 | $0.26 | $953 | 70,538 |
| 2022-12-14 | Schaffer Shane J. Chief Executive Officer | Purchase | +13,267 | $1.01 | $13K | 31,500 |
| 2022-12-14 | Callahan Jennifer L. Corporate Controller | Purchase | +7,548 | $0.99 | $7K | 34,508 |
| 2022-12-13 | Schaffer Shane J. Chief Executive Officer | Purchase | +1,733 | $1.01 | $2K | 18,233 |
| 2022-12-13 | Schaffer Shane J. Chief Executive Officer | Purchase · Warrant to Purchase Common Stock | +396 | $0.26 | $103 | 66,896 |
| 2022-12-13 | Werth Peter J. Director | Purchase | +28,934 | $0.98 | $28K | 975,165 |
| 2022-11-29 | Callahan Jennifer L. Corporate Controller | Purchase | +1,530 | $0.98 | $1K | 26,960 |
| 2022-11-28 | Callahan Jennifer L. Corporate Controller | Purchase | +3,487 | $0.98 | $3K | 25,430 |
| 2022-11-23 | Myers Laurie EVP and COO | Purchase | +1,111 | $0.90 | $1,000 | 48,263 |
| 2022-11-23 | Gilgallon Craig S. EVP, GC and Secretary | Purchase | +3,575 | $0.84 | $3K | 9,550 |
| 2022-11-22 | GIVENS GREGG WM Director | Purchase | +85,000 | $0.88 | $75K | 154,318 |
| 2022-09-30 | Silva Raul R. EVP and CSO | Grant or award · Stock Option (right to Buy) | +15,032 | 15,032 | ||
| 2022-09-08 | Callahan Jennifer L. Corporate Controller | Purchase | +3,500 | $1.50 | $5K | 21,943 |
| 2022-09-06 | Werth Peter J. Director | Purchase | +74,500 | $1.52 | $113K | 946,231 |
Page 7 of 11 · 202 trades